혈관조영 카테터 시장은 몇개의 요인에 의해 수요가 급증하고 있습니다. 주로 관상동맥 질환 및 뇌졸중 등 심혈관질환의 유병률 증가에 의해 진단 및 개입 시술의 필요성이 높아지고 있습니다. 이러한 카테터는 혈관을 가시화하고, 혈관성형술 및 스텐트 유치술과 같은 저침습치료를 시행하는데 있어서 중요한 역할을 담당하고 있습니다. 시장 규모는 2024년에 13억 7,000만 달러를 돌파하며, 2031년에는 약 24억 2,000만 달러에 달합니다.
카테터 기술의 발전으로 재료의 개선, 직경의 미세화, 영상 처리 기능의 강화 등 보다 효과적이고 최소 침습적인 카테터가 개발되어 수요가 더욱 증가하고 있습니다. 심혈관 질환에 취약한 고령화 인구 증가는 시장 확대에 기여하고 있습니다. 비용 효율적이고 효율적인 혈관조영 카테터에 대한 수요가 증가함에 따라 2024-2031년 연평균 7.38%의 성장률을 보일 것으로 예상됩니다.
혈관조영 카테터 시장 정의/개요
혈관조영 카테터는 혈관조영술 중 엑스레이 영상으로 볼 수 있도록 혈액 동맥에 조영제를 주입하는 특수 의료기기입니다. 이 카테터는 심장의 동맥, 정맥 및 심실의 구조와 기능을 확인하는 데 도움이되며 임상의가 막힘, 동맥류 및 선천성 기형을 포함한 광범위한 심혈관 질환을 감지하고 치료할 수 있도록 도와줍니다. 혈관조영 카테터는 동맥(가장 흔하게는 대퇴동맥 또는 요골동맥)을 통해 삽입되어 영상 기술을 통해 원하는 부위로 향하는 가느다란 플렉서블 튜브입니다.
혈관조영 카테터는 주로 진단 및 중재적 심장병학에서 관상동맥, 말초 및 뇌혈관조영술에 사용됩니다. 이 카테터는 혈관 성형술, 스텐트 삽입술, 색전술과 같은 치료 시술에도 사용됩니다. 이미징 기술의 발전과 보다 유연하고 생체적합성 및 조향이 가능한 카테터의 개발로 인해 혈관조영 카테터의 미래는 보다 정확하고 덜 침습적인 시술이 포함될 것으로 보입니다. 전 세계에서 심혈관 질환의 유병률 증가와 영상 유도 치료 증가로 인해 혈관조영 카테터에 대한 수요는 로봇 보조 카테터 치료 및 실시간 영상 기술 증가로 인해 계속 증가할 것으로 예상됩니다.
카테터 설계의 발전, 특히 마이크로카테터 및 조종 가능한 카테터와 같은 기술 혁신이 혈관조영 카테터 시장을 주도하고 있습니다. 이러한 기술 발전은 복잡한 혈관 네트워크에서 보다 정확한 탐색을 가능하게 하여 혈관조영술 치료의 정확성과 안전성을 향상시키며, FDA가 2020년에 43개의 새로운 심혈관 기기를 승인했는데, 그 중 상당수가 카테터 기술을 수반하는 것으로, 이러한 첨단 기술의 사용이 증가하고 있음을 보여줍니다. 증가하고 있음을 보여줍니다.
고령화 인구는 혈관조영 카테터 시장에 박차를 가할 가능성이 높습니다. 세계 인구의 고령화에 따라 관상동맥 질환 및 죽상동맥경화증과 같은 심혈관 질환의 유병률이 증가하고 있으며, 이러한 질환은 혈관조영술을 통해 자주 발견되고 치료됩니다. 유엔에 따르면 65세 이상 인구는 2019년 7억 3천만 명에서 2050년 15억 명으로 두 배로 증가할 것으로 예측됩니다. 이러한 노인 인구의 급격한 증가는 심혈관 검사 및 치료에 대한 수요를 촉진하고 혈관조영 카테터 시장의 확대를 가속화할 것으로 보입니다.
혈관조영 카테터 시장 성장에는 혈관조영술의 높은 비용이 영향을 미칠 것으로 예상됩니다. 이러한 가격은 특히 의료 자원이 부족한 중저소득 국가에서 이러한 시술에 대한 접근성을 제한하고 총 수요를 감소시킬 수 있습니다. 병원과 의료시설은 첨단 혈관조영 장비와 카테터에 투자할 때에도 비용 제약에 직면할 수 있습니다. 선진국의 경우에도 환자 지출은 특히 보험 적용이 제한적인 시스템에서 시술을 지연시키거나 축소하여 시장 성장을 제한할 수 있습니다.
위험과 합병증은 혈관조영 카테터 시장의 성장에 영향을 미칠 수 있습니다. 이 카테터는 중요한 심혈관 시술에 사용되므로 감염, 알레르기 반응, 혈관 손상, 조영제 유발 신증과 같은 위험은 환자와 의료진 모두에게 우려를 불러일으킬 수 있습니다. 규제 당국의 감시가 강화되고 의료진이 다른 진단 방법을 찾게 되면, 이러한 위험에 대한 인식이 높아져 시장 확대가 제한될 수 있습니다. 또한 안전에 대한 우려는 시장 역학에 영향을 미쳐 더 안전한 솔루션에 대한 수요를 증가시키면서 비용을 증가시켜 보급을 저해할 수 있습니다.
The angiography catheters market is experiencing a surge in demand due to several factors. Primarily, the increasing prevalence of cardiovascular diseases, such as coronary artery disease and stroke, has led to a greater need for diagnostic and interventional procedures. These catheters play a crucial role in visualizing blood vessels and performing minimally invasive treatments like angioplasty and stent placement. The market size surpass USD 1.37 Billion valued in 2024 to reach a valuation of aroundUSD 2.42 Billion by 2031.
Advancements in catheter technology, including improved materials, smaller diameters, and enhanced imaging capabilities, have made them more effective and less invasive, further driving demand. The growing aging population, which is more susceptible to cardiovascular diseases, is contributing to the market's expansion. The rising demand for cost-effective and efficient angiography catheters is enabling the market to grow at aCAGR of 7.38% from 2024 to 2031.
Angiography Catheters Market: Definition/ Overview
Angiography catheters are specialized medical devices that inject contrast media into blood arteries to make them visible on X-ray imaging during angiography operations. These catheters aid in seeing the structure and function of the heart's arteries, veins, and chambers, allowing clinicians to detect and treat a wide range of cardiovascular diseases including blockages, aneurysms, and congenital anomalies. Angiography catheters are flexible, thin tubes that are put via an artery, most commonly the femoral or radial artery, and directed to the desired region using imaging techniques.
Angiography catheters are primarily used in diagnostic and interventional cardiology to perform coronary, peripheral, and cerebral angiograms. These catheters are also used in therapeutic procedures like angioplasty, stent implantation, and embolization. With developments in imaging technology and the development of more flexible, biocompatible, and steerable catheters, the future of angiography catheters will involve more precise and least invasive procedures. The growing global prevalence of cardiovascular illnesses, combined with an increase in image-guided therapies, predicts that demand for angiography catheters will continue to climb, possibly due to developments in robotic-assisted catheterization and increased real-time imaging technology.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Advancements in catheter design, notably innovations such as micro-catheters and steerable catheters, are propelling the angiography catheter market. These technical advancements enable more precise navigation in complex vascular networks, improving the accuracy and safety of angiography treatments. The FDA's approval of 43 new cardiovascular devices in 2020, many of which involve catheter technology, demonstrates the rising use of these advanced technologies.
The elderly population is likely to fuel the angiography catheter market. As the world population ages, the prevalence of cardiovascular disorders such as coronary artery disease and atherosclerosis rises, which are frequently detected and treated via angiography treatments. According to the United Nations, the number of individuals aged 65 and more is predicted to double from 703 million in 2019 to 1.5 billion by 2050. This considerable increase in the older population will fuel demand for cardiovascular tests and therapies, accelerating the expansion of the angiography catheters market.
The high cost of angiography operations is anticipated to have an impact on market growth for angiography catheters. These prices can limit access to such procedures, particularly in low- and middle-income countries with limited healthcare resources, lowering total demand. Hospitals and healthcare facilities may also face cost constraints when investing in sophisticated angiography equipment and catheters. Patient expenses, even in industrialized countries, may result in delayed or curtailed procedures, especially in systems with limited insurance coverage, limiting market growth.
Risks and complications can have an impact on the growth of the angiography catheter market. These catheters are utilized in crucial cardiovascular procedures, and any dangers, including infections, allergic reactions, blood vessel damage, or contrast-induced nephropathy, might cause concern among both patients and healthcare personnel. Increased awareness of these dangers may restrict market expansion as regulatory scrutiny intensifies and healthcare professionals turn to alternate diagnostic methods. Furthermore, safety concerns may influence market dynamics, pushing demand for safer solutions while potentially increasing costs, and discouraging widespread use.
Drug-
eluting balloon catheter segments dominate the angiography catheters market. The integration of drug-eluting technology is projected to propel the drug-eluting balloon catheters sector of the angiography catheters market. Drug-eluting balloon catheters direct therapeutic substances to the target site, lowering restenosis and enhancing patient outcomes in vascular procedures. This technology, together with increased rates of cardiovascular disease and a shift toward minimally invasive procedures, is expected to increase demand and expand the market for these advanced catheters.
The prevalence of cardiovascular illnesses is projected to drive the expansion of the drug-eluting balloon (DEB) catheter segment in the angiography catheter market. As cardiovascular disorders such as coronary artery disease and peripheral artery disease become more common, owing to aging populations and lifestyle choices, there is a greater need for better treatment alternatives. DEB catheters, which release medicines to prevent arterial re-narrowing (restenosis) during angioplasty, are a targeted and successful treatment that reduces the need for stent insertion. This makes them an appealing alternative for healthcare professionals, accelerating their adoption in response to the growing burden of cardiovascular disease.
Hospital's segment fastest leading in the angiography catheters market. The large volume of patients requiring cardiovascular operations is expected to boost the angiography catheters market in the hospital segment. As the prevalence of cardiovascular illnesses rises worldwide, there is an increasing demand for diagnostic and interventional techniques that rely primarily on angiography catheters. These devices are critical for diagnosing and treating coronary artery disease and peripheral vascular disease. Furthermore, advances in catheter technology and increased healthcare investments in cardiovascular care are propelling this market forward, as hospitals strive to improve diagnostic accuracy and treatment efficacy.
The availability of advanced medical equipment and qualified workers is expected to drive the hospital segment's growth in the angiography catheter market. This expansion is being driven by the rising need for precise diagnostic and therapeutic treatments that necessitate high-quality angiography catheters. Advanced equipment improves the accuracy and efficiency of these treatments, while trained clinicians make the best use of the technology, resulting in better patient results. Furthermore, the increased prevalence of cardiovascular disorders, as well as the necessity for sophisticated imaging procedures to manage these conditions, are driving up demand for advanced angiography catheters in hospitals.
North America is dominating in angiography catheters market thanks to its improved health infrastructure. The growing progress of healthcare infrastructure will drive the North American angiography catheters market. North America excels in this market due to its advanced healthcare infrastructure, large patient population, and high frequency of cardiovascular disorders. With cardiovascular disease expected to affect more than 40% of the US population by 2030, the demand for sophisticated diagnostic tools such as angiography catheters will increase. Furthermore, the strong presence of major industry players and ongoing advancements will drive market expansion in the region.
The North American market for angiography catheters is predicted to rise due to an aging population. According to the United States Census Bureau, the baby boomer group will account for 73 million of the senior population by 2030. Because cardiovascular disease risk rises with age, this demographic trend is projected to boost the demand for diagnostic equipment such as angiography catheters. As a result, North America's expanding elderly population will significantly drive market demand, as more individuals will need cardiovascular evaluations and treatments.
Asia Pacific is rapidly growing in the angiography catheters market owing to its increased awareness of cardiovascular health. The increasing frequency of cardiovascular diseases (CVDs), which are the main cause of death worldwide, particularly in Asia, accounts for 35% of all deaths. As people become more conscious of their cardiovascular health, they seek diagnostic and interventional procedures, which increases the demand for angiography catheters. Furthermore, the region's aging population and expanding healthcare facilities drive up demand, positioning the market for significant development.
Government initiatives are propelling the Asia-Pacific angiography catheters market. Efforts to enhance healthcare access and affordability are driving market growth, as demonstrated in China, where coronary angiography operations increased by about 50% between 2015 and 2019, owing to rising healthcare costs and an aging population. Similarly, India's rising prevalence of cardiovascular illnesses, which is expected to exceed 103 million cases by 2030, and Japan's consistent increase in percutaneous coronary interventions (PCI) drive demand for angiography catheters, generating significant potential possibilities in the area.
The angiography catheters market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.
The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the optogenetics market include: